Atlas Trials

Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study)

Clinical trial NCT04589949 · TERMINATED

Trial details

NCT number
NCT04589949
Sponsor
Erasmus Medical Center
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Covid19
Start date
2020-10-12
Primary completion
2021-10-01
Enrollment
420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.